Graeme Alexander

Active 1982–2022

86
Papers
22,792
Citations
77
h-index
86
i10-index

Citations

Citations per year for Graeme Alexander1978: 1 citations1979: 1 citations1983: 2 citations1984: 4 citations1985: 2 citations1986: 1 citations1987: 8 citations1988: 4 citations1989: 9 citations1990: 12 citations1991: 28 citations1992: 41 citations1993: 44 citations1994: 36 citations1995: 57 citations1996: 63 citations1997: 43 citations1998: 71 citations1999: 75 citations2000: 82 citations2001: 57 citations2002: 68 citations2003: 102 citations2004: 102 citations2005: 120 citations2006: 136 citations2007: 140 citations2008: 100 citations2009: 135 citations2010: 185 citations2011: 191 citations2012: 198 citations2013: 228 citations2014: 189 citations2015: 230 citations2016: 160 citations2017: 156 citations2018: 181 citations2019: 523 citations2020: 517 citations2021: 522 citations2022: 389 citations2023: 298 citations2024: 458 citations2025: 210 citations2026: 6 citations1980–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,066 citing papers, 22.5% of this breakdownUnited Kingdom: 1,150 citing papers, 12.5% of this breakdownChina: 629 citing papers, 6.9% of this breakdownGermany: 535 citing papers, 5.8% of this breakdownItaly: 516 citing papers, 5.6% of this breakdownFrance: 403 citing papers, 4.4% of this breakdownCanada: 356 citing papers, 3.9% of this breakdownSpain: 307 citing papers, 3.4% of this breakdownJapan: 297 citing papers, 3.2% of this breakdownNetherlands: 275 citing papers, 3% of this breakdownAustralia: 264 citing papers, 2.9% of this breakdownSwitzerland: 194 citing papers, 2.1% of this breakdown
0%22.5%Other 23.8%

Fields

  • Medicine71.4%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Immunology and Microbiology9%
  • Pharmacology, Toxicology and Pharmaceutics4.6%
  • Engineering0.9%
  • Neuroscience0.4%
  • Other1.4%

Topics

  • Liver Disease Diagnosis and Treatment10%
  • Hepatitis C virus research6.2%
  • Liver Disease and Transplantation5.3%
  • Liver Diseases and Immunity5.1%
  • Hepatitis B Virus Studies4.4%
  • Organ Transplantation Techniques and Outcomes3.1%
  • Other65.9%

Coauthors

All papers

Open in search
  1. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2014 cited by 617

  2. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ulrich Beuers, Rinse K. Weersma, Cisca Wijmenga, Hanns–Ulrich Marschall, Piotr Milkiewicz, Albert Parés, Kimmo Kontula, Olivier Chazouillères, Pietro Invernizzi, Elizabeth C. Goode, Kelly Spiess, Carmel Moore, Jennifer Sambrook, Willem H. Ouwehand, David J. Roberts, John Danesh, Annarosa Floreani, Aliya Gulamhusein, John E. Eaton, Stefan Schreiber, Catalina Coltescu, Christopher L. Bowlus, Velimir A. Luketic, Joseph A. Odin, Kapil Chopra, Kris V. Kowdley, Naga Chalasani, Michael P. Manns, Brijesh Srivastava, George Mells, Richard Sandford, Graeme Alexander, Daniel J. Gaffney, Roger W. Chapman, Gideon M. Hirschfield, Mariza de Andrade, Simon Rushbrook, André Franke, Tom H. Karlsen, Konstantinos N. Lazaridis, Carl A. Anderson - Nature Genetics 2016 cited by 382

  3. Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan Davies, Kim B. Jensen, Matthias Zilbauer, William Gelson, Graeme Alexander, Sanjay Sinha, Nicholas R. F. Hannan, Thomas A. Wynn, Tom H. Karlsen, Espen Melum, Athina E. Markaki, Kourosh Saeb‐Parsy, Ludovic Vallier - Nature Medicine 2017 cited by 294

  4. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

    Authors: , , , , , , , , , , , , - Gut 2019 cited by 287

  5. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease

    Authors: , , , , , , , , , - Journal of Hepatology 2012 cited by 313

  6. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

    Authors: , , , , , , , , , , , , , - Gut 2018 cited by 336

  7. Early indicators of prognosis in fulminant hepatic failure

    Authors: , , , - Gastroenterology 1989 cited by 2,104

  8. The UK‐PBC risk scores: Derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2015 cited by 350

  9. Senescence in chronic liver disease: Is the future in aging?

    Authors: , - Journal of Hepatology 2016 cited by 165

  10. Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2018 cited by 103

  11. Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression

    Authors: , , , , , , - Cells 2022 cited by 44

  12. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2009 cited by 2,160

  13. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation

    Authors: , , , , , , , , , , , , , , , , - Nature Biotechnology 2015 cited by 395

  14. Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid

    Authors: , , , , , , , , , , , - Gastroenterology 2012 cited by 384

  15. Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease

    Authors: , , , , , , , , , , - PLoS ONE 2013 cited by 109

  16. Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study

    Authors: , , , , , , , , , , , - Hepatology 2013 cited by 218

  17. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

    Authors: , , , , , , , , , , , , , , , , , - Science 2004 cited by 1,190

  18. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter J.P. Croucher, Martina Sterneck, Andreas Teufel, Andrew L. Mason, Janna Saarela, Virpi Leppä, Ruslan Dorfman, Domenico Alvaro, Annarosa Floreani, Suna Önengüt-Gümüşcü, Stephen S. Rich, Wesley K. Thompson, Andrew J. Schork, Sigrid Næss, Ingo Thomsen, Gabriele Mayr, Inke R. König, Kristian Hveem, Isabelle Cleynen, Javier Gutierrez‐Achury, Isis Ricaño-Ponce, David A. van Heel, Einar Björnsson, Richard Sandford, Peter R. Durie, Espen Melum, Morten H. Vatn, Mark S. Silverberg, Richard H. Duerr, Leonid Padyukov, Stephan Brand, Miquel Sans, Vito Annese, Jean–Paul Achkar, Kirsten Muri Boberg, Hanns–Ulrich Marschall, Olivier Chazouillères, Christopher L. Bowlus, Cisca Wijmenga, Erik Schrumpf, Séverine Vermeire, Mario Albrecht, John D. Rioux, Graeme Alexander, Annika Bergquist, Judy H. Cho, Stefan Schreiber, Michael P. Manns, Martti Färkkilâ, Anders M. Dale, Roger W. Chapman, Konstantinos N. Lazaridis, André Franke, Carl A. Anderson, Tom H. Karlsen - Nature Genetics 2013 cited by 398

  19. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eugenio Gaudio, Vincenzo Ronca, Giulia Bonato, Laura Cristoferi, Federica Malinverno, Alessio Gerussi, Deborah Stocken, Heather J. Cordell, Gideon M. Hirschfield, Graeme Alexander, Richard Sandford, David Jones, Pietro Invernizzi, George Mells, Caradog Thomas, Meshbah Rahman, Tom Yapp, Chin Lye Ch’ng, Melanie Harrison, Richard Sturgess, Roman Galaska, Chris Healey, Jessica Whiteman, Marek Czaijkowski, Catherine Gray, Anton Gunasekera, Pranab Gyawli, Purushothaman Premchand, Steven Mann, Keith Elliott, Kapil Kapur, Alan Watson, Graham R. Foster, Paul Trembling, Javaid Subhani, Rory Harvey, Roger McCorry, Carolyn Adgey, Lucie Hobson, Caroline Mulvaney-Jones, Richard J. Evans, Thiriloganathan Mathialahan, David Ramanaden, Jaber Gasem, Greta Van Duyvenvoorde, C Shorrock, Katie Seward, Paul Southern, Jeremy Tibble, Ruth Penn, David Gorard, Jane Maiden, Rose Damant, Altaf Palegwala, Susan Jones, Graeme Alexander, George Mells, Richard Sandford, Jessica Whiteman, Sunil Dolwani, Martin Prince, Valéria Damasceno Silvestre, Matthew Foxton, Eleanor Dungca, Harriet Mitchison, Natalie Wheatley, Ian Gooding, Helen Doyle, Mazn Karmo, Melanie Kent and 304 more - ˜The œLancet. Gastroenterology & hepatology 2018 cited by 163

  20. Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver

    Authors: , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 77

  21. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

    Authors: , , , , , , , , , , , , , - Gut 2010 cited by 345

  22. Ageing, telomeres, senescence, and liver injury

    Authors: , , - Journal of Hepatology 2010 cited by 179

  23. Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom

    Authors: , , , , , , , , , - Clinical Gastroenterology and Hepatology 2018 cited by 85

  24. Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JHEP Reports 2021 cited by 69